Clinical Trials Related to Merck Sharp & Dohme LLC

Related studies linked through entity extraction aliases.

Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED)

Status: COMPLETED
Phase: N/A

PegIntron Injection Surveillance Plan (Study P04123)

Status: COMPLETED
Phase: N/A

Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252)

Status: COMPLETED
Phase: N/A

Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206)

Status: TERMINATED
Phase: N/A

Assessment of the Social Cost of Crohn's Disease: Economic and Quality of Life Aspects (Study P04560)

Status: COMPLETED
Phase: N/A

Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)

Status: COMPLETED
Phase: N/A

Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)

Status: COMPLETED
Phase: N/A

Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)

Status: COMPLETED
Phase: N/A

Rate and Predictors of Relapse in the Treatment of Hepatitis C (Study P05181)

Status: COMPLETED
Phase: N/A

Pharmacoeconomic Study Assessing the Cost of Chronic Hepatitis C Treatment With Peginterferon Alfa-2b (PegIntron) and Ribavirin (Rebetol) in the Czech Republic (Study P04588)(COMPLETED)

Status: COMPLETED
Phase: N/A

MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)

Status: COMPLETED
Phase: PHASE3

A Study to Test the Tolerability of an Investigational Electroporation Device in Healthy Adults (V930-001)

Status: COMPLETED
Phase: PHASE1

Investigation to Identify Predictors of Response to a Treatment With Montelukast

Status: COMPLETED
Phase: PHASE4

Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma

Status: COMPLETED
Phase: PHASE2

Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.

Status: COMPLETED
Phase: EARLY_PHASE1

Efficacy of Losartan in Preventing Progression of COPD

Status: COMPLETED
Phase: PHASE4

HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer

Status: COMPLETED
Phase: PHASE1

Phase III Placebo-controlled Study of V260 (RotaTeq™) in Japanese Healthy Infants (V260-029)(COMPLETED)

Status: COMPLETED
Phase: PHASE3

Cerebrospinal Fluid (CSF) Raltegravir Substudy

Status: COMPLETED
Phase: N/A

A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)

Status: COMPLETED
Phase: PHASE3